Trials / Conditions / HIV Pre-exposure Prophylaxis

HIV Pre-exposure Prophylaxis

18 registered clinical trials studyying HIV Pre-exposure Prophylaxis — 11 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Optimizing PrEP Uptake for African American Women in the South by Empowering Women to Make Informed HIV Preven NCT07173816	University of Georgia	N/A
Not Yet Recruiting	Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Person NCT06799702	University of Georgia	N/A
Not Yet Recruiting	HIV Testing Counselor-led Care to Catalyze Integration of PrEP Delivery in Family Planning Clinics NCT07089966	University of Washington	N/A
Not Yet Recruiting	HIV Pre-Exposure Prophylaxis (PrEP) Linkage With Immediate Medications in the Emergency Department Study NCT07462611	University of Texas Southwestern Medical Center	N/A
Not Yet Recruiting	Long-Acting Injectable HIV PrEP PROs NCT07379658	Anupama Raghuram MD	—
Recruiting	Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP NCT07218211	Duke University	Phase 4
Recruiting	A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010) NCT07071623	Merck Sharp & Dohme LLC	Phase 3
Recruiting	A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011) NCT07044297	Merck Sharp & Dohme LLC	Phase 3
Recruiting	Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP) NCT07047716	Gilead Sciences	Phase 3
Completed	A Study of MK-8527 in Healthy Lactating Female Participants (MK-8527-009) NCT06580587	Merck Sharp & Dohme LLC	Phase 1
Recruiting	Client-Centered Care Coordination for Black Men Who Have Sex With Men NCT06056544	University of Maryland, Baltimore	N/A
Active Not Recruiting	Evaluating the Effectiveness of a Mobile HIV Prevention App to Increase HIV and Sexually Transmitted Infection NCT06205368	Emory University	N/A
Completed	Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-0 NCT06045507	Merck Sharp & Dohme LLC	Phase 2
Completed	Supporting Tailored And Responsive PrEP in Rural North Carolina NCT05984030	University of North Carolina, Chapel Hill	N/A
Completed	A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE) NCT06783192	Merck Sharp & Dohme LLC	Phase 1
Terminated	MyPrEP Plus: Development and Pilot Testing of Novel Preexposure Prophylaxis Decision Support Tools for Transge NCT07146139	Public Health Foundation Enterprises, Inc.	N/A
Completed	Adapting an Adolescent Friendly PrEP Program for Uasin Gishu County-Kenya NCT05545449	Indiana University	—
Recruiting	Vienna HIV Infection Via Sex Study NCT05326061	Medical University of Vienna	—